AUTONOMIX MEDICAL, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
AUTONOMIX MEDICAL, INC. (AMIX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $5.00 thousand for the 12-month period ending 2025-03-31, per its 10-K filed 2026-05-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-05-27
- AUTONOMIX MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $5.00K, a 99.71% decline from fiscal 2024.
- AUTONOMIX MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $1.70M.
- AUTONOMIX MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2025-03-31 | $5.00K 10-K · filed 2026-05-27 | |
| 2024-03-31 | $1.70M 10-K · filed 2025-05-29 | $1.70K 10-K · filed 2024-05-31 |
| 2023-03-31 | $0.00 10-K · filed 2024-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |